Back to search

Article

Effectiveness of BNT162b2 mRNA COVID-19 Third Vaccines During Pregnancy: A National Observational Study in Israel

2022-07-11

Abstract excerpt

Background: Current guidelines recommend a third dose of COVID-19 vaccine for pregnant women, although data regarding effectiveness during pregnancy are lacking.<br><br>Methods: We conducted a national, population-based, historical cohort study of all pregnant women in Israel who delivered between August 1, 2021 and March 22, 2022. Data were analyzed by COVID-19 waves (Delta variant in the summer of 2021 and Omicr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d6a576c4-528a-501a-86e5-2d87aa72ab2a
DOI
10.2139/ssrn.4159559
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effectiveness of BNT162b2 mRNA COVID-19 Third Vaccines During Pregnancy: A National Observational Study in IsraelDOI 10.2139/ssrn.4159559
Effectiveness of BNT162b2 mRNA COVID-19 third vaccines during pregnancy: A national observational study in IsraelSemantic proximity
Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine in PregnancySemantic proximity
Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in IsraelSemantic proximity
BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure; Analysis of Household Members of COVID-19 PatientsSemantic proximity
The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidenceSemantic proximity
Effectiveness of the BNT162b vaccine fourth dose in reducing SARS-CoV-2 infection among healthcare workers in Israel, a multi-center cohort studySemantic proximity
The Effectiveness of the First Dose of BNT162b2 Vaccine in Reducing SARS-CoV-2 Infection: Real-World EvidenceSemantic proximity
Analysis of uptake, effectiveness and safety of COVID-19 vaccinations in pregnancy using the QResearch® database: research protocol and statistical analysis planSemantic proximity
Effectiveness of BNT162b2 mRNA COVID-19 Vaccine Against SARS-CoV-2 Variant Beta (B.1.351) Among Persons Identified Through Contact Tracing in IsraelSemantic proximity
Waning of the Humoral Response to SARS-CoV-2 in Pregnancy is Variant-DependentSemantic proximity
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004)Semantic proximity
BNT162B2 mRNA Covid-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in the Medium - to Long-Term: A Retrospective Cohort StudySemantic proximity
Select a neighboring publication to make it the new centre.